TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia.

Kerry A Rogers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.